ArticleJSES international2026
Strong correlation of the Patient-Reported Outcomes Measurement Information System (PROMIS) upper extremity and Shoulder Arthroplasty Smart (SAS) score to legacy measures in shoulder arthroplasty patients.
Article in JSES international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Patient-reported outcome measures (PROMs) are vital for evaluating surgical outcomes. Legacy PROMs, such as the American Shoulder and Elbow Surgeons (ASES) score, have been the standard for examining upper extremity (UE) function but are not without limitations. Newer tools, such as the Patient-Reported Outcomes Measurement Information System (PROMIS) UE and Shoulder Arthroplasty Smart (SAS) score, offer potential improved sensitivity in assessing UE outcomes. The goal of this study was to assess the accuracy of both PROMIS UE and SAS to the established legacy ASES score. Methods: A retrospective study of patients who underwent primary shoulder arthroplasty from 2020 to 2022 was analyzed for PROMs using ASES, PROMIS UE, and SAS. Pearson correlation coefficients were obtained to compare ASES with PROMIS UE as well as ASES with SAS scores from patients with a minimum of 2-year follow-up. Ceiling effect analysis was conducted using ASES, PROMIS UE, and SAS scores. Results: A total of 70 patients met inclusion criteria and were analyzed. The mean final follow-up was 2.48 years. The correlation of ASES vs. PROMIS UE was noted to be excellent-good at 6-month (r = 0.647, Conclusions: The present study suggests PROMIS UE and SAS are effective, shoulder-specific alternatives to legacy instruments. Both instruments showed strong, increasing correlations with ASES through 2 years follow-up and demonstrated low ceiling effects, indicating sensitivity across a broad functional range. These results highlight the clinical utility of PROMIS UE and SAS for patient-centered outcome assessment in shoulder arthroplasty populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.